Also, anticitrullinated protein antibody (ACPA) is associated with aggressive rheumatoid diseases; their presence is associated with worsening of the prognosis in RA and greater cardiovascular manifestations [47]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.